Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Leukemia Research
|
December 5, 2003
Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma
Ted Wun, Hayes McKnight, Joseph M Tuscano
Journal of Autoimmunity
|
November 7, 2002
Phosphorylation abnormalities: NZB mice exhibit a B-cell signalling defect
Joseph M Tuscano, Tom C Hsu, Hayes McKnight, et al.
Journal of Hematology & Oncology
|
December 2, 2011
The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner
Shiloh M Martin, Eric Churchill, Hayes McKnight, et al.
Molecular Imaging and Biology
|
October 25, 2008
Imaging and pharmacokinetics of (64)Cu-DOTA-HB22.7 administered by intravenous, intraperitoneal, or subcutaneous injection to mice bearing non-Hodgkin's lymphoma xenografts
Shiloh M Martin, Robert T O'Donnell, David L Kukis, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Leukemia Research
|
December 5, 2003
Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma
Ted Wun, Hayes McKnight, Joseph M Tuscano
Journal of Autoimmunity
|
November 7, 2002
Phosphorylation abnormalities: NZB mice exhibit a B-cell signalling defect
Joseph M Tuscano, Tom C Hsu, Hayes McKnight, et al.
Journal of Hematology & Oncology
|
December 2, 2011
The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner
Shiloh M Martin, Eric Churchill, Hayes McKnight, et al.
Molecular Imaging and Biology
|
October 25, 2008
Imaging and pharmacokinetics of (64)Cu-DOTA-HB22.7 administered by intravenous, intraperitoneal, or subcutaneous injection to mice bearing non-Hodgkin's lymphoma xenografts
Shiloh M Martin, Robert T O'Donnell, David L Kukis, et al.
Page
of 1